13.10.2015 • NewsDede WillamsCRISPR/Cas9DuPont

DuPont and Caribou in Strategic Alliance

Delaware-based US chemical giant DuPont and Caribou Biosciences of California, a leading developer of CRISPR-Cas technologies for genome editing, have signed an agreement to cross-license their respective patent portfolios. The chemical producer also has taken a minority equity stake in Caribou to strengthen the working relationship.

Under the deal, financial terms of which have not been disclosed, DuPont will receive exclusive intellectual property rights for CRISPR-Cas technology applications in major row crops and non-exclusive rights in other agricultural and industrial bioscience applications.

The alliance foresees a multi-year research collaboration, with scientists from the two sides focused on enhancing the breadth, versatility and efficiency of the core CRISPR-Cas toolkit.

The technology is said to be capable of making exact changes to the DNA of most organisms. In plants, this editing capability can be applied to promote drought tolerance and disease resistance to protect plant health and increase crop yields. It also can provide direct consumer benefits like the removal of food allergens and the improvement of the nutrient composition of plant-derived oils.

“DuPont intends to lead in the application of CRISPR-Cas technology to improve agricultural productivity and enhance food security, said executive vice president, James C. Borel. He added that CRISPR-Cas could harbor significant potential to advance plant breeding and expand the range of agricultural solutions available to farmers. The first related products could be brought to market in the next five to 10 years, Borel suggested.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.